CLINICAL INFORMATION AND PHARMACOLOGY
Composition 1:
Each vial of Thymoenzym 2G in injectable form contains: 1000 mg, divided into 750 mg de lyophilised substances in 1 vial, consisting of: Extract of Adult Stem Cells, Freeze-dried during the Embryonic Phase, Total Thymus Extract, equivalent to 1,000 mg of fresh gland, and Adenosine Desaminase, Superoxide Dismutase, Glutathione Reductase, Glutathione-S-Transferase, Glutathione-Peroxidase, Amino Acid Preparation comprising: Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Tryptophan, Threonine and Valine.
Composition 2:
Each 10-ml/250-mg vial contains:
250 mg of Cellular Protoplasm, Lidocaine 2%, Sodium Chloride 0.9%, Water ppi QSP 100% and in 10 ml, of cellular protoplasm.
More Information |
||
| » Thymoenzym 2G » Clinical Information and Pharmacology » Mechanisms of Action » Pharmacokinetics |
» Indications » Oncology » Analysis » Clinical Studies |
» Bibliography » Exclusively For Doctors |